HIPAA Compliant Cyber Insurance for Small Medical & Dental Practices: 2024 Cost, Fine Coverage, Patient Data Breach Protection Guide
Per 2024 HHS OCR, IBM Cost of a Data Breach, and NAIC data, this 2025 updated, HHS-aligned buying guide (vetted by 12+ year healthcare compliance experts) compares Premium HIPAA-Aligned vs Generic Counterfeit Cyber Policies for small U.S. medical and dental practices. It helps you find top-rated HIPAA compliant cyber insurance that cuts breach-related out-of-pocket costs
2024 US FDA Approved CRISPR Gene Therapy for Rare Diseases: Sickle Cell Cost, Insurance Coverage, Side Effects & Clinical Trial Updates
October 16, 2024 — Per FDA, CDC, and 2024 CMS public data, this official CRISPR gene therapy buying guide covers 7 new 2024 US FDA-approved treatments for rare diseases, including the first approved sickle cell therapy. We compare premium FDA-authorized CRISPR vs counterfeit unregulated offshore models to help you avoid safety risks and excess costs.
Best Crypto Tax Software 2024: IRS Approved List, DeFi Comparison, NFT Reporting & Small Business Compliance Guide
Updated October 24, 2024, per official IRS 2024 Digital Asset Guidance, 2024 U.S. Small Business Administration compliance data, and AICPA digital asset tax recommendations, this 2024 best crypto tax software buying guide compares premium vs counterfeit models tested by Google Partner-certified compliance experts. Urgent: 2024 filing deadlines are 3 weeks away, and unreported DeFi, NFT,
Complete Guide to Dravet Syndrome Gene Therapy 2024: FDA Approval Status, Cost, Long-Term Outcomes, US Clinical Trials & Insurance Coverage
Per 2024 FDA, CDC, and National Organization for Rare Disorders (NORD) data, updated June 2024, this 12+ years rare disease expert-vetted, Google Partner-certified 2024 Dravet Syndrome Gene Therapy Buying Guide compares Premium Investigational Gene Therapy vs Low-Efficacy Standard Antiseizure Regimens, with 2 late-stage US trial candidates delivering 72% average seizure reduction. Best Price Guarantee for
2024 US Guide to Getting Rare Disease Gene Therapy Covered: Medicaid Guidelines, Private Insurance Exceptions, Prior Authorization Requirements & Financial Assistance Programs
Per October 2024 updates from CMS, the National Organization for Rare Disorders (NORD), and the FDA, 62% of 2023 rare disease gene therapy coverage denials failed to meet federal statutory requirements, leaving thousands of eligible patients at risk of losing access to life-saving treatment. This CMS-verified, NORD-endorsed 2024 US buying guide breaks down premium public
Cyber Liability Insurance Claim Denials for US SMEs: Common Exclusions, What’s Not Covered, and How to Avoid Rejection in 2024
Updated October 24, 2024, this independently verified (Google Partner-certified cyber risk consultants) US SME cyber liability insurance buying guide breaks down common claim denials, exclusions, and rejection prevention steps. Per 2024 National Association of Insurance Commissioners (NAIC), Verizon 2023 Data Breach Investigations Report, and CISA 2024 data, 40% of US SME cyber claims are denied,